CID 10371554

Trilobalicin

Structural Information

Molecular Formula
C35H62O8
SMILES
CCCCCCCCCCC(C1CCC(O1)C(CCC(C2CCC(O2)CCCCCC(CC3=CC(OC3=O)C)O)O)O)O
InChI
InChI=1S/C35H62O8/c1-3-4-5-6-7-8-9-13-16-29(37)33-21-22-34(43-33)31(39)19-18-30(38)32-20-17-28(42-32)15-12-10-11-14-27(36)24-26-23-25(2)41-35(26)40/h23,25,27-34,36-39H,3-22,24H2,1-2H3
InChIKey
FTBUPRVFMAYNFL-UHFFFAOYSA-N
Compound name
4-[7-[5-[1,4-dihydroxy-4-[5-(1-hydroxyundecyl)oxolan-2-yl]butyl]oxolan-2-yl]-2-hydroxyheptyl]-2-methyl-2H-furan-5-one
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

610.44446 Da
Monoisotopic Mass

7.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 611.45174 261.8
[M+Na]+ 633.43368 254.7
[M-H]- 609.43718 264.5
[M+NH4]+ 628.47828 261.8
[M+K]+ 649.40762 253.8
[M+H-H2O]+ 593.44172 256.8
[M+HCOO]- 655.44266 264.2
[M+CH3COO]- 669.45831 256.5
[M+Na-2H]- 631.41913 245.1
[M]+ 610.44391 265.1
[M]- 610.44501 265.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.